TIAA CREF Investment Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-28,093
| Closed | -$982K | – | 3086 |
|
|
2018
Q1 | $982K | Sell |
28,093
-15,342
| -35% | -$536K | ﹤0.01% | 2455 |
|
|
2017
Q4 | $1.85M | Buy |
43,435
+18,228
| +72% | +$776K | ﹤0.01% | 2182 |
|
|
2017
Q3 | $1.08M | Buy |
25,207
+4,241
| +20% | +$182K | ﹤0.01% | 2477 |
|
|
2017
Q2 | $777K | Buy |
20,966
+3,861
| +23% | +$143K | ﹤0.01% | 2667 |
|
|
2017
Q1 | $926K | Sell |
17,105
-1,436
| -8% | -$77.7K | ﹤0.01% | 2545 |
|
|
2016
Q4 | $985K | Sell |
18,541
-786
| -4% | -$41.8K | ﹤0.01% | 2545 |
|
|
2016
Q3 | $1.17K | Sell |
19,327
-7,446
| -28% | -$451 | ﹤0.01% | 2463 |
|
|
2016
Q2 | $1.76M | Buy |
26,773
+3,046
| +13% | +$201K | ﹤0.01% | 2203 |
|
|
2016
Q1 | $1.35M | Sell |
23,727
-652
| -3% | -$37K | ﹤0.01% | 2306 |
|
|
2015
Q4 | $5.73M | Sell |
24,379
-894
| -4% | -$210K | ﹤0.01% | 1472 |
|
|
2015
Q3 | $4M | Sell |
25,273
-758
| -3% | -$120K | ﹤0.01% | 1695 |
|
|
2015
Q2 | $9.85M | Buy |
26,031
+396
| +2% | +$150K | 0.01% | 1156 |
|
|
2015
Q1 | $10.7M | Buy |
25,635
+810
| +3% | +$339K | 0.01% | 1094 |
|
|
2014
Q4 | $6.8M | Sell |
24,825
-1,057
| -4% | -$289K | ﹤0.01% | 1404 |
|
|
2014
Q3 | $5.03M | Sell |
25,882
-787
| -3% | -$153K | ﹤0.01% | 1615 |
|
|
2014
Q2 | $6.53M | Buy |
26,669
+922
| +4% | +$226K | ﹤0.01% | 1478 |
|
|
2014
Q1 | $6.82M | Sell |
25,747
-389
| -1% | -$103K | ﹤0.01% | 1387 |
|
|
2013
Q4 | $9.49M | Buy |
26,136
+1,048
| +4% | +$381K | 0.01% | 1185 |
|
|
2013
Q3 | $13.3M | Sell |
25,088
-751
| -3% | -$399K | 0.01% | 930 |
|
|
2013
Q2 | $6.05M | Buy |
+25,839
| New | +$6.05M | ﹤0.01% | 1390 |
|